Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pre-exposure prophylaxis for HIV: effective and underused.
Hempel A, Biondi MJ, Baril JG, Tan DHS. Hempel A, et al. Among authors: tan dhs. CMAJ. 2022 Sep 6;194(34):E1164-E1170. doi: 10.1503/cmaj.220645. CMAJ. 2022. PMID: 36265058 Free PMC article. Review. No abstract available.
HIV pre-exposure prophylaxis.
Sharma M, Tan DH. Sharma M, et al. CMAJ. 2014 Oct 21;186(15):E588. doi: 10.1503/cmaj.140127. Epub 2014 Aug 5. CMAJ. 2014. PMID: 25096663 Free PMC article. Review. No abstract available.
Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.
Tan DHS, Hull MW, Yoong D, Tremblay C, O'Byrne P, Thomas R, Kille J, Baril JG, Cox J, Giguere P, Harris M, Hughes C, MacPherson P, O'Donnell S, Reimer J, Singh A, Barrett L, Bogoch I, Jollimore J, Lambert G, Lebouche B, Metz G, Rogers T, Shafran S; Biomedical HIV Prevention Working Group of the CIHR Canadian HIV Trials Network. Tan DHS, et al. CMAJ. 2017 Nov 27;189(47):E1448-E1458. doi: 10.1503/cmaj.170494. CMAJ. 2017. PMID: 29180384 Free PMC article. No abstract available.
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial.
Feld JJ, Kandel C, Biondi MJ, Kozak RA, Zahoor MA, Lemieux C, Borgia SM, Boggild AK, Powis J, McCready J, Tan DHS, Chan T, Coburn B, Kumar D, Humar A, Chan A, O'Neil B, Noureldin S, Booth J, Hong R, Smookler D, Aleyadeh W, Patel A, Barber B, Casey J, Hiebert R, Mistry H, Choong I, Hislop C, Santer DM, Lorne Tyrrell D, Glenn JS, Gehring AJ, Janssen HLA, Hansen BE. Feld JJ, et al. Among authors: tan dhs. Lancet Respir Med. 2021 May;9(5):498-510. doi: 10.1016/S2213-2600(20)30566-X. Epub 2021 Feb 5. Lancet Respir Med. 2021. PMID: 33556319 Free PMC article. Clinical Trial.
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286).
Klein MB, Young J, Ortiz-Paredes D, Wang S, Walmsley S, Wong A, Martel-Laferrière V, Pick N, Conway B, Angel J, Baril JG, Fraser C, Lebouché B, Tan DHS, Sandre R, Trottier S, Peiris H, Jayaraman J, Singer J; CTN 286 Study Investigators. Klein MB, et al. Among authors: tan dhs. Patient Prefer Adherence. 2022 Dec 13;16:3267-3281. doi: 10.2147/PPA.S379065. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 36536672 Free PMC article.
A 36-year-old man with hemoptysis.
Tan D, Hutcheon M, Chung TB. Tan D, et al. CMAJ. 2004 Sep 14;171(6):573. doi: 10.1503/cmaj.1040557. CMAJ. 2004. PMID: 15367458 Free PMC article. No abstract available.
143 results